Rhelion Life Sciences Corp

CSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026

Company Profile

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

ExchangeCSE

Market Capitalization12.28 mln

Float575 mln

Earnings Date12/02/2026

Piotroski F-Score

3 / 9

Below average

Beneish M-Score

0.28

Highly suspicious

Relative Strength

28 / 100

Underperforming

Debt / Equity

0.02

Debt-free

Pre-Tax Margin

-247%

Severely loss-making

ROE

-42.19

Deeply negative

Key Fundamentals

EPS-0.01

ROE-42.19

ROIC-62.37

ROA-35.03

EBITDA, mln-7.20

EV / EBITDA-0.68

EV / EBIT-0.64

Revenue, mln3.08

EV / Revenue1.58

Quote Details

Last 0.02

Change 0 (0%)

Open 0.02

Volume 2,156,942

Turnover 43,139

Average Volume 272,222

Financial Ratios

Pre-Tax Profit Margin-247

Current Ratio3.26

Price / Book0.81

Price / Tangible Book1.25

Debt / Equity0.02

Price / Sales3.57

Financial Strength

Altman Z-Score-1.38

Piotroski F-Score 3 / 9

Beneish M-Score0.28

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-20%	13 / 100
1 Month	-33.33%	23 / 100